Progestin News and Research

RSS

HRT shows promise in helping visual memory of postmenopausal women

Many women experience declines in their memory during and after menopause, a change thought to be due, in part, to the rapid hormonal changes they weather during that time.

20 Nov 2006

Wall Street Journal examines debate over alternative HRT to treat menopausal symptoms

The Wall Street Journal on Saturday examined the debate over the risks and efficacy of alternatives to hormone replacement therapy for treatment of menopausal symptoms.

23 Oct 2006

Contraceptive options in the U.S. examined

The New York Times on Tuesday examined contraceptive options in the U.S., where 60% of unplanned pregnancies occur among women who use contraception.

17 Oct 2006

Judge declares mistrial in case against Wyeth's Prempro

A judge in a Pennsylvania state court in Philadelphia on Wednesday declared a mistrial in a case in which a jury ruled that the use of Wyeth's combination hormone replacement therapy Prempro in part caused breast cancer to develop in a 66-year-old woman, the Wall Street Journal reports.

16 Oct 2006

Jury dismisses lawsuit against Wyeth in first Pempro case

A jury in a U.S. District Court in Little Rock, Ark., on Friday dismissed negligence charges in the first of about 5,000 lawsuits filed over Prempro, a combination hormone replacement therapy manufactured by Wyeth, and found the drug's design was not defective, Reuters reports.

20 Sep 2006

Hearing loss in older women linked to hormone replacement therapy

Researchers in the U.S. are suggesting that hormone replacement therapy (HRT) may possibly exacerbate hearing deficits in women who take it following the menopause.

5 Sep 2006

Estrogen and testosterone combination to treat menopause may increase risk of breast cancer

Women who take a combination of estrogen and testosterone to treat the symptoms of menopause may have an increased risk of breast cancer, according to an article in the July 24 issue of Archives of Internal Medicine.

25 Jul 2006

Matchstick-sized contraceptive implant that lasts for three years

The Food and Drug Administration in the U.S. has given approval for a new contraceptive which will protect women from pregnancy for as long as three years.

20 Jul 2006

FDA approves Implanon (etonogestrel implant) contraceptive

Organon announced today that the U.S. Food and Drug Administration (FDA) approved Implanon (etonogestrel implant) 68mg, the first and only single-rod implantable contraceptive that is effective for up to three years.

18 Jul 2006

Menopausal women don't get enough guidance on treatment options

Few women are consulting their doctors before opting to use herbal therapies and soy products to treat their menopausal symptoms, researchers at the Stanford University School of Medicine have found.

18 Jun 2006

Long term oestrogen-only hormone replacement therapy increases breast cancer risk

According to new research women who take oestrogen-only hormone replacement therapy for 20 years or longer to treat the symptoms of menopause, put themselves at greater risk of developing breast cancer.

10 May 2006

Long-term estrogen therapy may be related to a higher risk of breast cancer

Previous studies have linked the use of hormone therapy to breast cancer among postmenopausal women, but have primarily focused on the hormone combination of estrogen plus progestin, according to background information in the article.

9 May 2006

A contraceptive pill for men!

According to a Sydney scientist a hormone-based contraceptive for men has the ability to reverse its effect just four months after stopping its use.

1 May 2006

Hormone therapy associated with increased risk of breast cancer among black women

Previous research has suggested that the long-term use of female hormone therapy is associated with an increased risk of developing breast cancer, according to background information in the article.

13 Apr 2006

No evidence that taking estrogen alone increases the risk of breast cancer in postmenopausal women

The findings come three years after a related WHI study found that a different type of hormone therapy - which combined estrogen and progestin - did result in a higher risk of breast cancer among postmenopausal women.

13 Apr 2006

Environmental scientists identify new culprits in the cancer equation

In the granite-rich region of Western North Carolina, taking a daily shower could pose a risk of developing lung cancer. So could working from home every day. That's because granite emits a carcinogenic gas, radon.

13 Apr 2006

Estrogen-alone hormone therapy does not increase the risk of breast cancer in postmenopausal women

The results contrast with the previously reported WHI Estrogen plus Progestin Trial, which found an increase in breast cancer over about 5 years among those taking combined hormone therapy.

11 Apr 2006

Estrogen therapy increases the risk of blood clots in some women

According to new research postmenopausal women on estrogen therapy who have undergone a hysterectomy have an elevated risk of developing a blood clots in veins.

11 Apr 2006

Estrogen therapy may increase the risk of venous thrombosis

Estrogen therapy may increase the risk of venous thrombosis, the formation of blood clots in the veins, among postmenopausal women who have had their uterus removed, according to a study in the April 10 issue of Archives of Internal Medicine.

11 Apr 2006